Kusurinomadoguchi, Inc.
5592・Growth Market・Information & Communication
Governance
A company with a Board of Corporate Auditors (4 directors, of which 2 are outside directors). It has established a Board of Directors, a Board of Corporate Auditors, a Risk Management Committee, a Risk Management Meeting, and a Group Company Meeting, building a system for rapid decision-making and oversight through monthly Board of Directors meetings.
Risk Management
Based on the "Risk Management Meeting Regulations," the Company holds monthly risk management meetings to continuously monitor a wide range of risks, including sales-related risks, information leakage, systems, and personnel/labor matters. As a higher-level body, the Company has established a Risk Management Committee (held quarterly), building a hierarchical management framework spanning from policy decisions through to reporting to the Board of Directors. The Company maintains its information security framework through ISMS certification and Privacy Mark acquisition.
Shareholder Returns
For FY2026 (ending March 2026), the company paid a dividend of ¥38 per share (total dividends of ¥435 million, payout ratio of 14.4%). ¥40 per share is planned for FY2027 (ending March 2027). The basic policy is to continue stable dividends targeting a consolidated payout ratio of 15%. The company also conducted a share buyback (¥1,007 million) during the current period.
Dividend Policy
The basic policy is to continue stable dividends with a target consolidated payout ratio of 15%. Dividends are basically paid twice a year, consisting of an interim dividend (¥0) and a year-end dividend. The FY2026 (ending March 2026) result was ¥38 per share (total dividends of ¥435 million, consolidated payout ratio of 14.4%). The forecast for FY2027 (ending March 2027) is ¥40 per share (consolidated payout ratio forecast of 14.8%).
ESG
The company positions solving social issues through its healthcare-domain medical platform business as the core of its sustainability efforts, contributing to more efficient use of medical resources through online prescription reception, electronic Okusuri Techo (medication notebooks), and pharmaceutical dead-stock matching, among other initiatives. On the human capital front, the policy is to secure and develop a diverse workforce, although no numerical targets have been set; the company discloses a female manager ratio of 6.0% and a male childcare leave uptake rate of 44.4%.
Last updated: June 26, 2026